Morningside Venture Investments Ltd
Insider CIK 1543112 · LQDA 10% owner · APLS 10% owner · KZR 10% owner · AMLX 10% owner · APMD 10% owner · GRNA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 1,088,986 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 9,227,454 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 75,624 | $14.40 | $1.09M | 75,624 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 75,624 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 75,624 | — | $0 | 75,624 | SEC↗ |
| APMD Apnimed, Inc. | P Buy | 2026-08-03 | 2026-08-05 | 312,500 | $16.00 | $5.00M | 7,152,713 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 6,840,213 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 6,840,213 | — | $0 | 6,840,213 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 6,840,213 | — | $0 | 6,840,213 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 1,088,986 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion deriv | 2026-08-03 | 2026-08-05 | 9,227,454 | — | $0 | 0 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 75,624 | — | — | 75,624 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 75,624 | — | — | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 75,624 | $14.40 | $1.09M | 75,624 | SEC↗ |
| APMD Apnimed, Inc. | P Buy | 2026-08-03 | 2026-08-05 | 312,500 | $16.00 | $5.00M | 7,152,713 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 6,840,213 | — | — | 6,840,213 | SEC↗ |
| APMD Apnimed, Inc. | J Other | 2026-08-03 | 2026-08-05 | 6,840,213 | — | — | 0 | SEC↗ |
| APMD Apnimed, Inc. | C Conversion | 2026-08-03 | 2026-08-05 | 6,840,213 | — | — | 6,840,213 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | G Gift | 2023-08-15 | 2023-08-17 | 2,000,000 | — | $0 | 4,997,302 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | G Gift | 2023-08-15 | 2023-08-17 | 3,500,000 | — | $0 | 1,947,993 | SEC↗ |
| GRNA GreenLight Biosciences Hol | J Other | 2023-07-24 | 2023-07-25 | 16,919,155 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-29 | 2023-03-31 | 29,048 | $30.45 | $884.5K | 6,997,302 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-28 | 2023-03-29 | 100,000 | $30.37 | $3.04M | 7,026,350 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-27 | 2023-03-29 | 28,000 | $30.80 | $862.4K | 7,126,350 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-27 | 2023-03-29 | 32,964 | $30.25 | $997.2K | 7,154,350 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 34,641 | $31.69 | $1.10M | 7,216,121 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 28,807 | $32.17 | $926.7K | 7,187,314 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 9,122 | $32.55 | $296.9K | 7,250,762 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-15 | 2023-03-16 | 108,934 | $33.12 | $3.61M | 7,300,950 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-15 | 2023-03-16 | 41,066 | $33.68 | $1.38M | 7,259,884 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-14 | 2023-03-16 | 70,714 | $34.54 | $2.44M | 7,409,884 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-03-02 | 2023-03-06 | 50,000 | $33.75 | $1.69M | 7,480,598 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-23 | 2023-02-24 | 1,111 | $36.24 | $40.3K | 7,580,598 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-23 | 2023-02-24 | 48,889 | $35.55 | $1.74M | 7,581,709 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-22 | 2023-02-24 | 39,916 | $35.91 | $1.43M | 7,640,682 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-22 | 2023-02-24 | 10,084 | $36.34 | $366.5K | 7,630,598 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-22 | 2023-02-28 | 47,888 | $34.70 | $1.66M | 7,532,710 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | S Sale | 2023-02-22 | 2023-02-28 | 2,112 | $35.34 | $74.6K | 7,530,598 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-02-06 | 2023-02-07 | 40,000 | $6.88 | $275.2K | 5,447,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-02-03 | 2023-02-07 | 25,000 | $7.15 | $178.8K | 5,487,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 50,000 | $7.19 | $359.5K | 5,512,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 40,000 | $6.95 | $278.0K | 5,562,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-31 | 2023-02-01 | 30,000 | $7.08 | $212.4K | 5,602,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-30 | 2023-02-01 | 30,000 | $6.91 | $207.3K | 5,632,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-25 | 2023-01-27 | 50,000 | $6.85 | $342.5K | 5,662,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-24 | 2023-01-25 | 80,000 | $6.98 | $558.4K | 5,712,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-23 | 2023-01-25 | 80,000 | $6.81 | $544.8K | 5,792,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-17 | 2023-01-19 | 6,114 | $6.79 | $41.5K | 5,872,993 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-13 | 2023-01-17 | 1,971 | $7.15 | $14.1K | 5,879,107 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-12 | 2023-01-17 | 5,000 | $6.77 | $33.9K | 5,881,078 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-06 | 2023-01-09 | 3,000 | $6.89 | $20.7K | 5,886,078 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-05 | 2023-01-09 | 12,162 | $6.97 | $84.8K | 5,889,078 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-04 | 2023-01-05 | 30,000 | $7.17 | $215.1K | 5,901,240 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 500 | $7.10 | $3.5K | 5,931,240 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2022-12-29 | 2023-01-05 | 25,000 | $7.10 | $177.5K | 5,931,740 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2022-10-04 | 2022-10-05 | 3,612 | $8.82 | $31.9K | 6,076,740 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2022-10-03 | 2022-10-05 | 28,700 | $8.78 | $252.0K | 6,080,352 | SEC↗ |
| GRNA GreenLight Biosciences Hol | P Buy | 2022-08-11 | 2022-08-15 | 3,061,224 | $3.92 | $12.00M | 15,919,155 | SEC↗ |
| ENVI GreenLight Biosciences Hol | C Conversion deriv | 2022-02-02 | 2022-02-04 | 1,000,000 | $10.00 | $10.00M | 0 | SEC↗ |
| ENVI GreenLight Biosciences Hol | C Conversion deriv | 2022-02-02 | 2022-02-04 | 12,858,188 | — | $0 | 0 | SEC↗ |
| GRNA GreenLight Biosciences Hol | C Conversion deriv | 2022-02-02 | 2022-03-17 | 1,000,000 | $10.00 | $10.00M | 0 | SEC↗ |
| GRNA GreenLight Biosciences Hol | C Conversion deriv | 2022-02-02 | 2022-03-17 | 12,857,931 | — | $0 | 0 | SEC↗ |
| ENVI GreenLight Biosciences Hol | C Conversion | 2022-02-02 | 2022-02-04 | 12,858,188 | — | $0 | 12,858,188 | SEC↗ |
| ENVI GreenLight Biosciences Hol | P Buy | 2022-02-02 | 2022-02-04 | 1,000,000 | — | $0 | 13,858,188 | SEC↗ |
| GRNA GreenLight Biosciences Hol | C Conversion | 2022-02-02 | 2022-03-17 | 12,857,931 | — | $0 | 12,857,931 | SEC↗ |
| GRNA GreenLight Biosciences Hol | P Buy | 2022-02-02 | 2022-03-17 | 1,000,000 | — | $0 | 13,857,931 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-01-25 | 6,410,964 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-01-25 | 974,107 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-01-25 | 1,621,544 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-01-25 | 1,409,035 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-03-17 | 6,410,964 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-03-17 | 974,107 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-03-17 | 1,621,544 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion deriv | 2022-01-11 | 2022-03-17 | 1,409,035 | — | $0 | 0 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-11 | 2022-01-25 | 10,415,650 | — | $0 | 10,415,650 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2022-01-11 | 2022-01-25 | 263,158 | $19.00 | $5.00M | 10,678,808 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | P Buy | 2022-01-11 | 2022-03-17 | 263,158 | $19.00 | $5.00M | 10,678,808 | SEC↗ |
| AMLX Amylyx Pharmaceuticals, In | C Conversion | 2022-01-11 | 2022-03-17 | 10,415,650 | — | $0 | 10,415,650 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2021-11-18 | 2021-11-18 | 250,000 | $40.00 | $10.00M | 12,806,342 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2020-02-04 | 2020-02-06 | 3,800,000 | $2.60 | $9.88M | 6,109,052 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2020-01-13 | 2020-01-21 | 540,540 | $37.00 | $20.00M | 12,556,342 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2019-03-11 | 2019-03-13 | 441,176 | $17.00 | $7.50M | 12,015,802 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-21 | 2018-09-24 | 40,000 | $19.84 | $793.6K | 11,574,626 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-20 | 2018-09-24 | 19,599 | $18.79 | $368.3K | 11,512,902 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-20 | 2018-09-24 | 21,724 | $19.43 | $422.1K | 11,534,626 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-19 | 2018-09-19 | 60,000 | $18.09 | $1.09M | 11,493,303 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-18 | 2018-09-19 | 40,000 | $18.47 | $738.8K | 11,433,303 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-17 | 2018-09-19 | 8,600 | $18.84 | $162.0K | 11,393,303 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-09-17 | 2018-09-19 | 31,400 | $18.50 | $580.9K | 11,384,703 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 18,996 | — | $0 | 18,996 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 3,420,516 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion deriv | 2018-07-30 | 2018-08-01 | 1,849,490 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | J Other deriv | 2018-07-30 | 2018-08-01 | 319,664 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 109,909 | — | $0 | 552,728 | SEC↗ |
| LQDA Liquidia Technologies Inc | C Conversion | 2018-07-30 | 2018-08-01 | 442,819 | — | $0 | 442,819 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,007,422 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,051,630 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 1,007,422 | — | $0 | 2,059,052 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2018-06-25 | 2018-06-27 | 250,000 | $15.00 | $3.75M | 2,309,052 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 1,051,630 | — | $0 | 1,051,630 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-13 | 17,200,000 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-13 | 4,476,275 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-13 | 259,302 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion deriv | 2017-11-13 | 2017-11-13 | 1,054,544 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | C Conversion | 2017-11-13 | 2017-11-13 | 10,778,303 | — | $0 | 10,778,303 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2017-11-13 | 2017-11-13 | 575,000 | $14.00 | $8.05M | 11,353,303 | SEC↗ |